A 59-year-old male patient with a significant thyroid enlargement was recently treated at the CK Birla Hospital® as part of the hospital’s ongoing commitment to improving clinical excellence delivery to the world. The patient had thyroid swelling for a number of years, and with time, it affected the entire right neck, making it difficult to move the neck. The patient put off having surgery for many years because he was worried about the outcome and potential difficulties afterward.
In thyroid surgeries performed at the best hospitals in the world, there is a 25% chance of calcium derangement caused by accidental removal of or damage to the parathyroid, which regulates calcium levels in the body and is located very close to the thyroid gland, and an 8% chance of injury to the Recurrent Larangeal Nerve, the voice nerve that is also located just below the thyroid gland.
Dr. Mandeep Singh Malhotra, Director of Surgical Oncology at CK Birla Hospital®, and his team advised thyroidectomy treatment using NIFI and nerve monitoring after examining the patient. During thyroid surgery, NIFI uses infrared technology to locate and protect the parathyroid glands. By lowering the calcium derangement following thyroid surgery to 1 percent, the use of NIFI provides significant benefits to patients. The voice nerve can be located and preserved with the aid of a nerve monitor.
Dr. Mandeep Singh Malhotra, Director of Surgical Oncology at CK Birla Hospital®, commented on the case and stated, “This technology was previously only available from abroad, making it an expensive treatment option; however, it is now available in Delhi, India at the CK Birla Hospital®, making treatment safer, more accessible, and more affordable for Indian patients.
This cutting-edge method has been used in six thyroid operations; three patients had thyroid cancer and three had sizable colloid goitres. None of the six patients experienced calcium derangement after surgery.
During surgery, near-infrared imaging is a useful tool for locating the parathyroid gland. Patients can receive improved clinical outcomes thanks to its availability in India. The CK Birla Hospitaladoption ®’s of this technology is a step in the direction of the government of India’s Make in India initiative.
“We are committed to fulfilling our aim of offering global standards of healthcare by leveraging cutting-edge medical advances and practises for excellent patient outcomes,” stated Mr. Akshat Seth, Chief Executive Officer of CK Birla Healthcare, in a speech given on the occasion.